Dietary Antioxidants During Cancer Chemotherapy: Impact on Chemotherapeutic Effectiveness and Development of Side Effects
Top Cited Papers
- 1 May 2000
- journal article
- review article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 37 (1), 1-18
- https://doi.org/10.1207/s15327914nc3701_1
Abstract
Several studies suggest that dietary supplementation with antioxidants can influence the response to chemotherapy as well as the development of adverse side effects that results from treatment with antineoplastic agents. Administration of antineoplastic agents results in oxidative stress, i.e., the production of free radicals and other reactive oxygen species (ROS). Oxidative stress reduces the rate of cell proliferation, and that occurring during chemotherapy may interfere with the cytotoxic effects of antineoplastic drugs, which depend on rapid proliferation of cancer cells for optimal activity. Antioxidants detoxify ROS and may enhance the anticancer effects of chemotherapy. For some supplements, activities beyond their antioxidant properties, such as inhibition of topoisomerase II or protein tyrosine kinases, may also contribute. ROS cause or contribute to certain side effects that are common to many anticancer drugs, such as gastrointestinal toxicity and mutagenesis. ROS also contribute to side effec...Keywords
This publication has 149 references indexed in Scilit:
- Genistein-Mediated Attenuation of Tamoxifen-Induced Antagonism from Estrogen Receptor-Regulated GenesBiochemical and Biophysical Research Communications, 1998
- Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicityEuropean Journal Of Cancer, 1997
- Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: A further pitfall in the use of the MTT assay for evaluating cell growth and survivalEuropean Journal Of Cancer, 1993
- Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drugChemico-Biological Interactions, 1989
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988
- Bioflavonoid interaction with rat uterine type ii binding sites and cell growth inhibitionJournal of Steroid Biochemistry, 1988
- Protective effect of endogenous coenzyme Q on both lipid peroxidation and respiratory chain inactivation induced by an adriamycin-iron complexBiochemical and Biophysical Research Communications, 1987
- Tyrosine protein kinase activity in the DMBA-induced rat mammary tumor: Inhibition by quercetinBiochemical and Biophysical Research Communications, 1984
- Inhibition by adriamycin of the mitochondrial biosynthesis of coenzyme Q10 and implication for the cardiotoxicity of adriamycin in cancer patientsBiochemical and Biophysical Research Communications, 1977
- Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activityBiochemical and Biophysical Research Communications, 1974